ATAD3A and Alzheimer disease: Notably, we observed an approximately twofold increase in the number of PLA-positive puncta in the postmortem cortex of both 5XFAD mice and AD patients after staining with anti-ATAD3A and anti-FACL4 (a MAM marker) antibodies (Fig. 2a, b).